No headlines found.
Business Wire (Thu, 28-Mar 7:30 AM ET)
Business Wire (Thu, 29-Feb 6:00 AM ET)
Business Wire (Fri, 23-Feb 7:30 AM ET)
Business Wire (Thu, 15-Feb 7:00 AM ET)
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
Business Wire (Thu, 1-Feb 4:01 PM ET)
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Ironwood Pharmaceuticals - Class A trades on the NASDAQ stock market under the symbol IRWD.
As of April 18, 2024, IRWD stock price declined to $7.60 with 2,970,111 million shares trading.
IRWD has a beta of 0.43, meaning it tends to be less sensitive to market movements. IRWD has a correlation of 0.01 to the broad based SPY ETF.
IRWD has a market cap of $1.19 billion. This is considered a Small Cap stock.
Last quarter Ironwood Pharmaceuticals - Class A reported $118 million in Revenue and $.00 earnings per share. This beat revenue expectation by $73,000 and missed earnings estimates by -$.21.
In the last 3 years, IRWD stock traded as high as $15.70 and as low as $7.53.
The top ETF exchange traded funds that IRWD belongs to (by Net Assets): IJR, XBI, CALF, VTI, VB.
IRWD has underperformed the market in the last year with a price return of -32.3% while the SPY ETF gained +22.3%. IRWD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.5% and -6.3%, respectively, while the SPY returned +6.1% and -3.8%, respectively.
IRWD support price is $7.45 and resistance is $7.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRWD stock will trade within this expected range on the day.